Suppr超能文献

胎儿暴露于母体阿片类维持治疗后四岁时的神经发育挑战。

Neurodevelopmental challenges at age four following fetal exposure to maternal opioid maintenance treatment.

作者信息

Kanervo Minna M, Tupola Sarimari J, Nikkola Eeva M, Gissler Mika, Kahila Hanna K, Rantakari Krista M

机构信息

University of Helsinki Doctoral School, Helsinki, Finland.

Children's Hospital, Helsinki University Hospital, Pediatric Research Center, and University of Helsinki, Helsinki, Finland.

出版信息

Pediatr Res. 2025 Mar 27. doi: 10.1038/s41390-025-04029-6.

Abstract

BACKGROUND

The impact of intrauterine exposure to maternal opioid use disorder (OUD) and opioid maintenance treatment (OMT) on child development is not fully understood. This population-based cohort study investigated the neurodevelopmental and behavioral outcomes of four-year-old children prenatally exposed to maternal OMT, hypothesizing greater challenges compared to their same-aged peers in Finland.

METHODS

Children with intrauterine exposure to buprenorphine±naloxone or methadone (n = 123) were compared with typically developing children (n = 434) using standardized language, motor-perceptual, and attention-behavioral skills screening tests. ICD-10 diagnoses for developmental and behavioral disorders were compared with national data from 50,457 Finnish children. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to assess risks.

RESULTS

Children with prenatal OMT exposure exhibited significantly higher rates of developmental challenges as indicated by screening tests and ICD-10 diagnoses, including speech and language disorders, ADHD, conduct, emotional, and social disorders (F80, F90-94), with ORs ranging from 8.97 to 210.21. Additional risk factors included male sex (p < 0.001), methadone (p = 0.004), illicit drug exposure (p = 0.011), and domestic violence (p = 0.032).

CONCLUSION

Children born to mothers with OUD and OMT face significantly elevated risks of developmental and behavioral challenges. Close monitoring, stable environment and early support for these children with multiple risk factors are crucial.

IMPACT

This population-based cohort study demonstrates that children with in-utero exposure to maternal OMT are at high risk of neurodevelopmental, emotional and behavioral difficulties at age four. Our results particularly add new knowledge of specific domains (skills) in neurodevelopmental screening tests and ICD-10 diagnoses in these children. Beyond OMT, multiple additional risk factors such as fetal exposures to illicit substances or other harmful substances and postnatal environmental instability further compound the likelihood of later-life impairments. These findings emphasize the critical need for comprehensive follow-up, stable environment, and early interventions for this vulnerable group.

摘要

背景

子宫内暴露于母亲阿片类物质使用障碍(OUD)和阿片类物质维持治疗(OMT)对儿童发育的影响尚未完全明确。这项基于人群的队列研究调查了产前暴露于母亲OMT的4岁儿童的神经发育和行为结果,假设与芬兰的同龄儿童相比,他们面临更大的挑战。

方法

使用标准化语言、运动感知和注意力行为技能筛查测试,将子宫内暴露于丁丙诺啡±纳洛酮或美沙酮的儿童(n = 123)与发育正常的儿童(n = 434)进行比较。将发育和行为障碍的国际疾病分类第十版(ICD - 10)诊断结果与来自50457名芬兰儿童的国家数据进行比较。计算优势比(OR)和95%置信区间(CI)以评估风险。

结果

产前暴露于OMT的儿童在筛查测试和ICD - 10诊断中表现出明显更高的发育挑战率,包括言语和语言障碍、注意力缺陷多动障碍(ADHD)、品行、情绪和社交障碍(F80,F90 - 94),OR范围为8.97至210.21。其他风险因素包括男性(p < 0.001)、美沙酮(p = 0.004)、非法药物暴露(p = 0.011)和家庭暴力(p = 0.032)。

结论

患有OUD和接受OMT治疗的母亲所生的儿童面临发育和行为挑战风险显著升高。对这些具有多种风险因素的儿童进行密切监测、提供稳定环境和早期支持至关重要。

影响

这项基于人群的队列研究表明,子宫内暴露于母亲OMT的儿童在4岁时存在神经发育、情感和行为困难的高风险。我们的结果特别增加了关于这些儿童神经发育筛查测试和ICD - 10诊断中特定领域(技能)的新知识。除了OMT之外,诸如胎儿暴露于非法物质或其他有害物质以及产后环境不稳定等多种额外风险因素进一步增加了日后出现障碍的可能性。这些发现强调了对这一弱势群体进行全面随访、提供稳定环境和早期干预的迫切需求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验